BARCLAYS PLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,495
-25.0%
786,793
+17.6%
0.00%0.0%
Q2 2023$3,327
+34.5%
669,197
+33.7%
0.00%
+100.0%
Q1 2023$2,474
-7.0%
500,651
+18.3%
0.00%0.0%
Q4 2022$2,661
-99.9%
423,053
+33.1%
0.00%
-75.0%
Q3 2022$3,432,000
+880.6%
317,766
+935.8%
0.00%
Q2 2022$350,000
-63.2%
30,679
-70.6%
0.00%
-100.0%
Q1 2022$951,000
-68.2%
104,371
-48.0%
0.00%0.0%
Q4 2021$2,994,000
+166.4%
200,664
+358.7%
0.00%0.0%
Q3 2021$1,124,000
-55.1%
43,750
-54.4%
0.00%0.0%
Q2 2021$2,503,000
-45.2%
95,934
-25.9%
0.00%
-50.0%
Q1 2021$4,571,000
+194.7%
129,518
+110.9%
0.00%
+100.0%
Q4 2020$1,551,000
-48.1%
61,405
-22.6%
0.00%
-50.0%
Q3 2020$2,991,000
-21.2%
79,304
-10.5%
0.00%
-33.3%
Q2 2020$3,795,000
+215.2%
88,611
+43.0%
0.00%
+200.0%
Q1 2020$1,204,000
-3.5%
61,982
+28.9%
0.00%0.0%
Q4 2019$1,248,000
+43.4%
48,086
+50.8%
0.00%0.0%
Q3 2019$870,000
+29.7%
31,889
+27.5%
0.00%
Q2 2019$671,000
-22.7%
25,006
-16.7%
0.00%
-100.0%
Q1 2019$868,000
+3114.8%
30,011
+2949.9%
0.00%
Q4 2018$27,0009840.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders